Annual total expenses:
$6.63B+$1.06B(+19.12%)Summary
- As of today (May 19, 2025), VRTX annual total expenses is $6.63 billion, with the most recent change of +$1.06 billion (+19.12%) on December 31, 2024.
- During the last 3 years, VRTX annual total expenses has risen by +$1.83 billion (+38.16%).
- VRTX annual total expenses is now at all-time high.
Performance
VRTX Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$1.74B-$60.60M(-3.37%)Summary
- As of today (May 19, 2025), VRTX quarterly total expenses is $1.74 billion, with the most recent change of -$60.60 million (-3.37%) on March 31, 2025.
- Over the past year, VRTX quarterly total expenses has increased by +$264.70 million (+17.95%).
- VRTX quarterly total expenses is now -4.95% below its all-time high of $1.83 billion, reached on June 30, 2021.
Performance
VRTX Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
VRTX Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.1% | +17.9% |
| 3 y3 years | +38.2% | +63.7% |
| 5 y5 years | +123.8% | +119.2% |
VRTX Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.1% | -3.4% | +63.7% |
| 5 y | 5-year | at high | +123.8% | -5.0% | +119.2% |
| alltime | all time | at high | >+9999.0% | -5.0% | >+9999.0% |
VRTX Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.74B(-3.4%) |
| Dec 2024 | $6.63B(+19.1%) | $1.80B(+9.7%) |
| Sep 2024 | - | $1.64B(-4.1%) |
| Jun 2024 | - | $1.71B(+16.0%) |
| Mar 2024 | - | $1.47B(-5.6%) |
| Dec 2023 | $5.56B(+21.8%) | $1.56B(+12.2%) |
| Sep 2023 | - | $1.39B(+2.6%) |
| Jun 2023 | - | $1.36B(+8.5%) |
| Mar 2023 | - | $1.25B(+0.5%) |
| Dec 2022 | $4.57B(-4.8%) | $1.24B(+5.4%) |
| Sep 2022 | - | $1.18B(+9.7%) |
| Jun 2022 | - | $1.08B(+1.4%) |
| Mar 2022 | - | $1.06B(-11.3%) |
| Dec 2021 | $4.80B(+43.7%) | $1.20B(+28.9%) |
| Sep 2021 | - | $928.40M(-49.3%) |
| Jun 2021 | - | $1.83B(+117.7%) |
| Mar 2021 | - | $840.40M(-4.7%) |
| Dec 2020 | $3.34B(+12.7%) | $881.53M(+2.0%) |
| Sep 2020 | - | $864.23M(+8.4%) |
| Jun 2020 | - | $797.25M(+0.5%) |
| Mar 2020 | - | $793.28M(-7.8%) |
| Dec 2019 | $2.96B(+24.2%) | $860.30M(+1.5%) |
| Sep 2019 | - | $847.54M(+26.2%) |
| Jun 2019 | - | $671.33M(+15.4%) |
| Mar 2019 | - | $581.63M(-18.5%) |
| Dec 2018 | $2.38B(+13.7%) | $713.38M(+23.2%) |
| Sep 2018 | - | $579.06M(-0.0%) |
| Jun 2018 | - | $579.22M(+13.1%) |
| Mar 2018 | - | $511.97M(-2.6%) |
| Dec 2017 | $2.10B(+23.9%) | $525.51M(-19.0%) |
| Sep 2017 | - | $648.53M(+32.9%) |
| Jun 2017 | - | $487.90M(+12.5%) |
| Mar 2017 | - | $433.88M(+3.6%) |
| Dec 2016 | $1.69B(+13.0%) | $418.84M(-3.2%) |
| Sep 2016 | - | $432.50M(+1.1%) |
| Jun 2016 | - | $427.91M(+3.9%) |
| Mar 2016 | - | $411.72M(-12.4%) |
| Dec 2015 | $1.50B(+22.5%) | $470.12M(+24.4%) |
| Sep 2015 | - | $378.02M(+12.8%) |
| Jun 2015 | - | $335.11M(+6.8%) |
| Mar 2015 | - | $313.77M(+6.7%) |
| Dec 2014 | $1.22B(-10.7%) | $294.02M(+4.9%) |
| Sep 2014 | - | $280.35M(-12.2%) |
| Jun 2014 | - | $319.23M(-2.8%) |
| Mar 2014 | - | $328.31M(-1.6%) |
| Dec 2013 | $1.37B(-7.4%) | $333.78M(+0.2%) |
| Sep 2013 | - | $333.21M(-9.2%) |
| Jun 2013 | - | $366.91M(+3.7%) |
| Mar 2013 | - | $353.72M(-3.6%) |
| Dec 2012 | $1.48B(+24.4%) | $366.88M(+9.1%) |
| Sep 2012 | - | $336.38M(-21.5%) |
| Jun 2012 | - | $428.48M(+23.6%) |
| Mar 2012 | - | $346.73M(+2.4%) |
| Dec 2011 | $1.19B(+41.9%) | $338.45M(+0.1%) |
| Sep 2011 | - | $338.11M(+20.9%) |
| Jun 2011 | - | $279.57M(+20.1%) |
| Mar 2011 | - | $232.80M(-0.7%) |
| Dec 2010 | $837.95M(+20.6%) | $234.41M(+5.3%) |
| Sep 2010 | - | $222.52M(+11.8%) |
| Jun 2010 | - | $199.08M(+9.4%) |
| Mar 2010 | - | $181.93M(+6.1%) |
| Dec 2009 | $694.67M(+9.6%) | $171.45M(-0.6%) |
| Sep 2009 | - | $172.42M(-1.5%) |
| Jun 2009 | - | $175.12M(-0.3%) |
| Mar 2009 | - | $175.68M(+1.5%) |
| Dec 2008 | $633.89M | $173.03M(+7.2%) |
| Sep 2008 | - | $161.35M(+1.0%) |
| Jun 2008 | - | $159.72M(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $139.78M(-1.9%) |
| Dec 2007 | $611.68M(+38.5%) | $142.46M(-7.4%) |
| Sep 2007 | - | $153.93M(-5.5%) |
| Jun 2007 | - | $162.91M(+6.9%) |
| Mar 2007 | - | $152.38M(+18.9%) |
| Dec 2006 | $441.74M(+46.0%) | $128.16M(+12.4%) |
| Sep 2006 | - | $114.00M(+5.1%) |
| Jun 2006 | - | $108.50M(+19.1%) |
| Mar 2006 | - | $91.08M(+8.7%) |
| Dec 2005 | $302.63M(+26.1%) | $83.75M(+8.6%) |
| Sep 2005 | - | $77.12M(+6.1%) |
| Jun 2005 | - | $72.66M(+5.2%) |
| Mar 2005 | - | $69.09M(+1.7%) |
| Dec 2004 | $239.95M(-0.8%) | $67.91M(+11.6%) |
| Sep 2004 | - | $60.86M(+3.3%) |
| Jun 2004 | - | $58.94M(+12.8%) |
| Mar 2004 | - | $52.24M(-12.6%) |
| Dec 2003 | $241.84M(-0.4%) | $59.78M(-0.1%) |
| Sep 2003 | - | $59.86M(-43.8%) |
| Jun 2003 | - | $106.58M(+3032.0%) |
| Mar 2003 | - | $3.40M(-91.4%) |
| Dec 2002 | $242.73M(+21.1%) | $39.49M(-43.7%) |
| Sep 2002 | - | $70.13M(+5.7%) |
| Jun 2002 | - | $66.36M(-0.6%) |
| Mar 2002 | - | $66.76M(+126.7%) |
| Dec 2001 | $200.40M(+5.1%) | $29.45M(-51.5%) |
| Sep 2001 | - | $60.77M(+56.3%) |
| Jun 2001 | - | $38.89M(+12.9%) |
| Mar 2001 | - | $34.45M(-68.1%) |
| Dec 2000 | $190.72M(+88.5%) | $108.02M(+272.0%) |
| Sep 2000 | - | $29.04M(+5.3%) |
| Jun 2000 | - | $27.58M(+5.9%) |
| Mar 2000 | - | $26.05M(-5.3%) |
| Dec 1999 | $101.20M(+31.6%) | $27.50M(+17.0%) |
| Sep 1999 | - | $23.50M(-8.5%) |
| Jun 1999 | - | $25.69M(+5.3%) |
| Mar 1999 | - | $24.40M(+1.2%) |
| Dec 1998 | $76.90M(+22.1%) | $24.10M(+17.6%) |
| Sep 1998 | - | $20.50M(+22.0%) |
| Jun 1998 | - | $16.80M(+8.4%) |
| Mar 1998 | - | $15.50M(-12.4%) |
| Dec 1997 | $63.00M(+8.4%) | $17.70M(-7.8%) |
| Sep 1997 | - | $19.20M(+43.3%) |
| Jun 1997 | - | $13.40M(+7.2%) |
| Mar 1997 | - | $12.50M(-50.6%) |
| Dec 1996 | $58.10M(+19.5%) | $25.30M(+145.6%) |
| Sep 1996 | - | $10.30M(-9.6%) |
| Jun 1996 | - | $11.40M(+2.7%) |
| Mar 1996 | - | $11.10M(+5.7%) |
| Dec 1995 | $48.60M(+20.6%) | $10.50M(+1.9%) |
| Sep 1995 | - | $10.30M(-38.7%) |
| Jun 1995 | - | $16.80M(+52.7%) |
| Mar 1995 | - | $11.00M(-0.9%) |
| Dec 1994 | $40.30M(+50.9%) | $11.10M(+7.8%) |
| Sep 1994 | - | $10.30M(+1.0%) |
| Jun 1994 | - | $10.20M(+15.9%) |
| Mar 1994 | - | $8.80M(-6.4%) |
| Dec 1993 | $26.70M(+93.5%) | $9.40M(+28.8%) |
| Sep 1993 | - | $7.30M(+30.4%) |
| Jun 1993 | - | $5.60M(+27.3%) |
| Mar 1993 | - | $4.40M(+12.8%) |
| Dec 1992 | $13.80M(+56.8%) | $3.90M(+8.3%) |
| Sep 1992 | - | $3.60M(+9.1%) |
| Jun 1992 | - | $3.30M(+10.0%) |
| Mar 1992 | - | $3.00M(+20.0%) |
| Dec 1991 | $8.80M(+37.5%) | $2.50M(+13.6%) |
| Sep 1991 | - | $2.20M(+4.8%) |
| Jun 1991 | - | $2.10M |
| Dec 1990 | $6.40M | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual total expenses?
- What is the all time high annual total expenses for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual total expenses year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly total expenses?
- What is the all time high quarterly total expenses for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly total expenses year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual total expenses?
The current annual total expenses of VRTX is $6.63B
What is the all time high annual total expenses for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual total expenses is $6.63B
What is Vertex Pharmaceuticals Incorporated annual total expenses year-on-year change?
Over the past year, VRTX annual total expenses has changed by +$1.06B (+19.12%)
What is Vertex Pharmaceuticals Incorporated quarterly total expenses?
The current quarterly total expenses of VRTX is $1.74B
What is the all time high quarterly total expenses for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly total expenses is $1.83B
What is Vertex Pharmaceuticals Incorporated quarterly total expenses year-on-year change?
Over the past year, VRTX quarterly total expenses has changed by +$264.70M (+17.95%)